December 21, 2011
AstraZeneca’s (AZ) proton pump inhibitor (PPI) Nexium (esomeprazole), which was launched in September, remained in the No. 1 position in the HP (medical institutions with 100 or more beds) market in the RepTrack Survey conducted by ANTERIO Inc. in November...read more